Moschetta, M., Mak, G., Hauser, J., Davies, C., Uccello, M., & Arkenau, H. (2017). Dabrafenib and trametinib activity in a patient with BRAF V600E mutated and microsatellite instability high (MSI-H) metastatic endometrial cancer. Exp Hematol Oncol.
Styl cytowania ChicagoMoschetta, Michele, Gabriel Mak, Joana Hauser, Catriona Davies, Mario Uccello, i Hendrik-Tobias Arkenau. "Dabrafenib and Trametinib Activity in a Patient With BRAF V600E Mutated and Microsatellite Instability High (MSI-H) Metastatic Endometrial Cancer." Exp Hematol Oncol 2017.
Styl cytowania MLAMoschetta, Michele, et al. "Dabrafenib and Trametinib Activity in a Patient With BRAF V600E Mutated and Microsatellite Instability High (MSI-H) Metastatic Endometrial Cancer." Exp Hematol Oncol 2017.